Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Med Phys. 2023 Jun 8;50(11):6864–6880. doi: 10.1002/mp.16548

Table 3.

The 3D Gamma passing rates between the dose distributions calculated on iCT and the corresponding sCTs of the 10 testing patients with a threshold of 3%/3mm/10% and 2%/2mm/10% for both the wMAE model and the M+S model, respectively.

PATIENT 3%/3mm/10% (wMAE) / (M+S) 2%/2mm/10% (wMAE) / (M+S)

#1 0.999 / 0.998 0.997 / 0.996
#2 * 0.996 / 0.965 0.98 / 0.926
#3 1.0 / 0.991 0.999 / 0.977
#4 1.0 / 0.999 0.999 / 0.999
#5 0.995 / 0.943 0.978 / 0.913
#6 * 0.966 / 0.976 0.921 / 0.934
#7 1.0 / 0.979 1.0 / 0.970
#8 1.0 / 0.979 1.0 / 0.970
#9 0.999 / 0.924 0.991 / 0.811
#10 * 0.921 / 0.924 0.899 / 0.902
Average 0.986±0.026 / 0.963±0.029 0.977±0.036 / 0.945±0.062
Average(photon) 0.995±0.012 / 0.974±0.029 0.987±0.029 / 0.955±0.067
Average(proton) 0.971±0.043 / 0.944±0.020 0.953±0.047 / 0.907±0.007
*

indicates that the patient was treated with proton therapy.